XML 120 R55.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income taxes (Tables)
12 Months Ended
Nov. 30, 2023
Major components of tax expense (income) [abstract]  
Summary of major component of income tax and deferred tax explanatory
The following table presents the components of the current and deferred tax expenses (recovery).
 
 
 
 
  
    
2023
 
  
    
2022
 
  
    
2021
 
 
 
       
Current tax expense
  
$
  450
 
  
$
443
 
  
$
63
 
 
 
       
Deferred tax expense (recovery)
  
     
  
     
  
     
       
Origination and reversal of temporary differences
  
$
(5,972)
 
  
$
(11,705)
 
  
$
(7,796)
 
       
Change in unrecognized deductible
temporary
 
differences
  
 
5,943
 
  
 
11,705
 
  
 
7,796
 
 
 
       
Total deferred tax expense (recovery)
  
$
(29)
 
  
$
-
 
  
$
-
 
 
 
       
Total current and deferred tax expense
  
$
421
 
  
$
443
 
  
$
63
 
 
 
Summary of reconciliation between effective and income tax amounts explanatory
Reconciliation between effective and applicable tax amounts.
 
 
 
 
  
    
2023
 
  
    
2022
 
  
    
2021
 
 
 
       
Income taxes at domestic tax statutory rate
  
$
(6,237)
 
  
$
(12,400)
 
  
$
(8,390)
 
       
Change in unrecognized deductible temporary differences
  
 
5,943
 
  
 
11,705
 
  
 
7,796
 
       
Impact of differences in statutory tax rates
  
 
(130)
 
  
 
102
 
  
 
64
 
       
Non-deductible
expenses and other
  
 
845
 
  
 
1,036
 
  
 
593
 
 
 
       
Total income tax expense
  
$
421
 
  
$
443
 
  
$
63
 
 
 
Summary of temporary difference, unused tax losses and unused tax credits
As at November 30, 2023 and 2022, the amounts and expiry dates of Canadian tax attributes for which no deferred tax asset was recognized were as follows:
 
 
 
 
  
 
 
  
2023
 
  
 
 
  
2022
 
 
 
 
  
   Federal
 
  
   Provincial
 
  
   Federal
 
  
   Provincial
 
 
 
         
Research and development expenses,
 without time limitation
  
$
87,151
 
  
$
105,549
 
  
$
86,768
 
  
$
105,174
 
         
Losses carried forward 2027
  
 
5,512
 
  
 
5,504
 
  
 
5,569
 
  
 
5,561
 
2028
  
 
33,761
 
  
 
16,258
 
  
 
34,110
 
  
 
16,426
 
2029
  
 
14,345
 
  
 
12,124
 
  
 
14,494
 
  
 
12,250
 
2030
  
 
8,423
 
  
 
8,420
 
  
 
8,510
 
  
 
8,507
 
2031
  
 
17,346
 
  
 
15,397
 
  
 
17,525
 
  
 
15,556
 
2032
  
 
11,752
 
  
 
10,791
 
  
 
11,874
 
  
 
10,902
 
2033
  
 
8,444
 
  
 
8,365
 
  
 
8,532
 
  
 
8,451
 
2034
  
 
7,733
 
  
 
7,665
 
  
 
7,813
 
  
 
7,744
 
2037
  
 
6,901
 
  
 
6,818
 
  
 
6,972
 
  
 
6,889
 
2038
  
 
2,013
 
  
 
1,938
 
  
 
2,034
 
  
 
1,958
 
2039
  
 
1,326
 
  
 
1,289
 
  
 
1,340
 
  
 
1,302
 
2040
  
 
7,242
 
  
 
7,218
 
  
 
7,317
 
  
 
7,292
 
2041
  
 
19,152
 
  
 
19,078
 
  
 
19,350
 
  
 
19,276
 
2042
  
 
29,042
 
  
 
28,885
 
  
 
31,181
 
  
 
31,190
 
2043
  
 
19,298
 
  
 
19,284
 
  
 
-
 
  
 
-
 
         
Other temporary differences,
 without time limitation
  
     
  
     
  
     
  
     
         
Excess of tax value of property and
 equipment over carrying value
  
 
435
 
  
 
420
 
  
 
1,000
 
  
 
454
 
         
Excess of tax value of intellectual
 property and patent fees over carrying value
  
 
10,660
 
  
 
10,656
 
  
 
10,765
 
  
 
10,765
 
         
Available deductions and other
  
 
73,522
 
  
 
32,536
 
  
 
69,448
 
  
 
28,034
 
 
Summary of amounts and expiry dates of tax attributes carry forward explanatory
The Company entered into the following transactions, which had no impact on its cash flows.
 
 
 
 
 
  
 2023
 
  
2022
 
  
2021
 
 
 
       
Deferred financing costs included in accounts
 payable and accrued liabilities
  
$
-
 
  
$
-
 
  
$
174
 
       
Additions to property and equipment included in accounts payable and
 accrued liabilities
  
 
-
 
  
 
156
 
  
 
-
 
       
Acquisition of derivative financial assets included in accounts payable and
 accrued liabilities
  
 
-
 
  
 
104
 
  
 
-
 
       
Additions to intangible assets included in accounts payable and accrued
 liabilities
  
 
-
 
  
 
2,832
 
  
 
-
 
       
Reclassification of other Deferred financing costs to deficit
  
 
-
 
  
 
38
 
  
 
-
 
       
Share issue cost included in accounts payable
 and accrued liabilities
  
 
505
 
  
 
37
 
  
 
-